5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

7 Countries

Phase II

Phase II: 2

Indications tested

Pulmonary sarcoidosis 2

Sponsors using this IMP

Molecure S.A. 2

All trials

2 total

A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised

2023-506642-23-00 Phase II 6 countries Molecure S.A.
A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Recruiting

2023-506642-23-01 Phase II 6 countries Molecure S.A.

Showing 1–2 of 2 trials

← All drugs A–Z